Translational Neurodegeneration

Naomi P. Visanji, et al.

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

LPETTET / Getty Images / iStock

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease

Articles

Recent

Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in

Authors: Jeroen Van Schependom, Kaat Guldolf, Marie Béatrice D’hooghe, Guy Nagels and Miguel D’haeseleer

Content type: Review

9 December 2019
Targeting γ-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models

Authors: Inger Lauritzen, Anaïs Bécot, Alexandre Bourgeois, Raphaëlle Pardossi-Piquard, Maria-Grazia Biferi, Martine Barkats and Fréderic Checler

Content type: Research

5 December 2019
Clinicopathologic characterization and abnormal autophagy of CSF1R-related leukoencephalopathy

Authors: Wo-Tu Tian, Fei-Xia Zhan, Qing Liu, Xing-Hua Luan, Chao Zhang, Liang Shang, Ben-Yan Zhang, Si-Jian Pan, Fei Miao, Jiong Hu, Ping Zhong, Shi-Hua Liu, Ze-Yu Zhu, Hai-Yan Zhou, Suya Sun, Xiao-Li Liu…

Content type: Research

2 December 2019
Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease

Authors: Xiaojun Guan, Tao Guo, Qiaoling Zeng, Jiaqiu Wang, Cheng Zhou, Chunlei Liu, Hongjiang Wei, Yuyao Zhang, Min Xuan, Quanquan Gu, Xiaojun Xu, Peiyu Huang, Jiali Pu, Baorong Zhang and Min-Ming Zhang

Content type: Research

15 November 2019
Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1–40 and cerebral vulnerability in normal aging

Authors: Marta Manzano-Crespo, Mercedes Atienza and Jose L. Cantero

Content type: Research

4 November 2019

Most recent articles RSS

View all articles

Editor-in-Chief

Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China

Journal news

For new submissions from 1st January 2019, authors will need to pay an article publishing charge (APC) of £1690.00/$2400.00/€2040.00 for each article submitted and accepted for publication in the journal.

Aims and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Translational Neurodegeneration

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease

Articles

Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in

Targeting γ-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models

Clinicopathologic characterization and abnormal autophagy of CSF1R-related leukoencephalopathy

Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease

Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1–40 and cerebral vulnerability in normal aging

Editor-in-Chief

Journal news

Aims and Scope

Affiliated with

Annual Journal Metrics

Translational Neurodegeneration

Contact us